Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Positron Emission Tomography (PET) Nuclear Medicine Market Report 2024

Positron Emission Tomography (PET) Nuclear Medicine Global Market Report 2025 – By Type (F-18, Rb-82, Other Types), By Procedure (Diagnostic Procedures, Single Photon Emission Computed Tomography Procedures, Positron Emission Tomography Procedures, Therapeutic Procedures, Beta Emitter Procedures, Alpha Emitter Procedures, Brachytherapy Procedures), By Application (Oncology, Cardiology, Neurology, Other Applications), By End User (Hospitals, Diagnostic Centers, Research Institutes) – Market Size, Trends, And Global Forecast 2025-2034

Positron Emission Tomography (PET) Nuclear Medicine Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Positron Emission Tomography (PET) Nuclear Medicine Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Positron Emission Tomography (PET) Nuclear Medicine Market Definition

Positron Emission Tomography (PET) nuclear medicine is a medical imaging method that employs radioactive materials to visualize and assess metabolic activities within the body. It uses a small amount of radioactive material called a radiotracer to detect changes at the cellular level, allowing doctors to diagnose diseases early.

The main types of positron emission tomography (PET) nuclear medicines are F-18, RB-82, and others. F-18, or fluorine-18, is a radioactive isotope commonly used in positron emission tomography imaging. It is used for various procedures such as diagnostic procedures, single photon emission computed tomography procedures, positron emission tomography procedures, therapeutic procedures, beta emitter procedures, alpha emitter procedures, and brachytherapy procedures and is applied for oncology, Cardiology, neurology, and others. It is used by several end users, including hospitals, diagnostic centers, and research institutes.

Positron Emission Tomography (PET) Nuclear Medicine Market Segmentation

The positron emission tomography (PET) nuclear medicine market covered in this report is segmented –

1) By Type: F-18, Rb-82, Other Types

2) By Procedure: Diagnostic Procedures, Single Photon Emission Computed Tomography Procedures, Positron Emission Tomography Procedures, Therapeutic Procedures, Beta Emitter Procedures, Alpha Emitter Procedures, Brachytherapy Procedures

3) By Application: Oncology, Cardiology, Neurology, Other Applications

4) By End User: Hospitals, Diagnostic Centers, Research Institutes

Subsegments:

1) By F-18 (Fluorine-18): F-18 FDG (Fluorodeoxyglucose), F-18 NaF (Sodium Fluoride), F-18 Fluorocholine

2) By Rb-82 (Rubidium-82): Rb-82 for Myocardial Perfusion Imaging, Rb-82 for Cardiac PET Stress Testing, Rb-82 for Other Cardiac Applications

3) By Other Types: C-11 (Carbon-11), N-13 (Nitrogen-13), O-15 (Oxygen-15), Ga-68 (Gallium-68)

Positron Emission Tomography (PET) Nuclear Medicine Market Size and growth rate 2025 to 2029: Graph

Positron Emission Tomography (PET) Nuclear Medicine Market Size 2025 And Growth Rate

The positron emission tomography (PET) nuclear medicine market size has grown rapidly in recent years. It will grow from $11.49 billion in 2024 to $13.2 billion in 2025 at a compound annual growth rate (CAGR) of 14.9%. The growth in the historic period can be attributed to increasing prevalence of cardiovascular diseases, increasing healthcare expenditures, increasing prevalence of urological diseases, increasing geriatric population, and increasing number of hospitals.

Positron Emission Tomography (PET) Nuclear Medicine Market Growth Forecast

The positron emission tomography (PET) nuclear medicine market size is expected to see rapid growth in the next few years. It will grow to $22.71 billion in 2029 at a compound annual growth rate (CAGR) of 14.5%. The growth in the forecast period can be attributed to increasing investment in research and development, rising demand for minimally invasive diagnostic techniques, expanding global healthcare infrastructure, increasing demand for food and pharmaceutical packaging, and rising prevalence of cancer. Major trends in the forecast period include technological advancements, multi-modality diagnosis, artificial intelligence integration, digital PET systems, and personalized medicine.

Book your 30 minutes free consultation with our research experts

Contact Us

Positron Emission Tomography (PET) Nuclear Medicine Market Driver: Impact Of Chronic Disease Prevalence On The PET Nuclear Medicine Market

The increasing prevalence of chronic diseases is expected to propel the growth of the positron emission tomography (PET) nuclear medicine market going forward. A chronic disease is a long-lasting health condition that typically persists for three months or more and may require ongoing medical attention or limit daily activities. The rise in chronic diseases is driven by factors such as an aging population, lack of physical activity, unhealthy eating habits, and environmental risks. PET nuclear medicine assists in managing chronic diseases by offering advanced imaging methods that enable early detection, precise diagnosis, and ongoing monitoring of these illnesses. For instance, in February 2024, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, around 20 million new cancer cases and 9.7 million cancer-related deaths were recorded in 2022. Additionally, by 2050, new cancer cases are expected to exceed 35 million, representing a 77% increase from the 2022 count. Therefore, the increasing prevalence of chronic diseases drives the growth of the positron emission tomography (PET) nuclear medicine market.

Global Positron Emission Tomography (PET) Nuclear Medicine Market Major Players

Major companies operating in the positron emission tomography (PET) nuclear medicine marker are Cardinal Health, Bayer AG, Medtronic plc, Siemens Healthineers AG, Fujifilm Holdings Corporation, Stryker Corporation, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Agfa HealthCare NV, Scripps Health, Shimadzu Corporation, Jubilant DraxImage Inc., Neusoft Medical Systems Co. Ltd., Toshiba America Medical Systems Inc., Lantheus Holdings Inc., Advanced Accelerator Applications, Bruker Corporation, Eckert & Ziegler Strahlen- und Medizintechnik AG, Canon Medical Systems Corporation, Digirad Corporation, NorthStar Medical Radioisotopes LLC, Mediso Medical Imaging Systems Ltd.

Global Positron Emission Tomography (PET) Nuclear Medicine Market Trend: Advancements In The PET Nuclear Medicine Market

Major companies operating in the positron emission tomography (PET) nuclear medicine market are developing technologically advanced products, such as PET slice scanners, to provide high-resolution images of metabolic activity. A PET slice scanner is a medical imaging device that combines positron emission tomography (PET) with advanced computing techniques to create detailed, cross-sectional images of metabolic processes in the body, allowing for detecting and monitoring diseases, particularly cancer. For instance, in July 2024, Positron Corporation, a US-based nuclear medicine company, launched the NeuSight PET-CT 3D 64-slice scanner. The NeuSight PET-CT 3D 64-slice scanner sets a new benchmark in imaging and diagnostic precision, combining advanced technology with patient comfort and operational efficiency. It is designed to transform cardiac PET imaging and offers exceptional value and performance at an unmatched price point, making it ideal for cardiology and oncology clinical studies. With superior data acquisition and innovative identification technology, the NeuSight PET-CT enhances scanning speed and accuracy, delivering comprehensive anatomic and functional imaging for heart, tumor, and brain studies across multiple molecular imaging applications.

Positron Emission Tomography (PET) Nuclear Medicine Market Merger And Acquisition: Lantheus Holdings Inc. Expands Portfolio With Acquisition Of Cerveau Technologies Inc.

In February 2023, Lantheus Holdings Inc., a US-based radiopharmaceutical company, acquired Cerveau Technologies Inc. for an undisclosed amount. This acquisition aligns with Lantheus's growth strategy by diversifying its radiopharmaceutical diagnostic imaging agent pipeline to include the most widely used Tau PET imaging agent for Alzheimer's disease. Additionally, it enhances its portfolio with an extensive array of academic collaborations and pharmaceutical partnerships. Cerveau Technologies Inc. is a US-based provider of F 18-labeled positron emission tomography imaging agent that targets Tau tangles in Alzheimer's disease.

Regional Outlook For The Global Positron Emission Tomography (PET) Nuclear Medicine Market

North America was the largest region in the positron emission tomography (PET) nuclear medicine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the positron emission tomography (PET) nuclear medicine marker report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the positron emission tomography (PET) nuclear medicine marker report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Positron Emission Tomography (PET) Nuclear Medicine Market?

The positron emission tomography (PET) nuclear medicine market consists of sales of radiotracers, dose calibrators, injection systems, patient monitoring systems and simulation tools. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Positron Emission Tomography (PET) Nuclear Medicine Industry?

The positron emission tomography (PET) nuclear medicine market research report is one of a series of new reports from The Business Research Company that provides positron emission tomography (PET) nuclear medicine market statistics, including positron emission tomography (PET) nuclear medicine industry global market size, regional shares, competitors with a positron emission tomography (PET) nuclear medicine market share, detailed positron emission tomography (PET) nuclear medicine market segments, market trends and opportunities, and any further data you may need to thrive in the positron emission tomography (PET) nuclear medicine industry. This positron emission tomography (PET) nuclear medicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Positron Emission Tomography (PET) Nuclear Medicine Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $13.2 billion
Revenue Forecast In 2034 $22.71 billion
Growth Rate CAGR of 14.5% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Type: F-18, Rb-82, Other Types
2) By Procedure: Diagnostic Procedures, Single Photon Emission Computed Tomography Procedures, Positron Emission Tomography Procedures, Therapeutic Procedures, Beta Emitter Procedures, Alpha Emitter Procedures, Brachytherapy Procedures
3) By Application: Oncology, Cardiology, Neurology, Other Applications
4) By End User: Hospitals, Diagnostic Centers, Research Institutes Subsegments: 1) By F-18 (Fluorine-18): F-18 FDG (Fluorodeoxyglucose), F-18 NaF (Sodium Fluoride), F-18 Fluorocholine
2) By Rb-82 (Rubidium-8
2): Rb-82 for Myocardial Perfusion Imaging, Rb-82 for Cardiac PET Stress Testing, Rb-82 for Other Cardiac Applications
3) By Other Types: C-11 (Carbon-11), N-13 (Nitrogen-1
3), O-15 (Oxygen-1
5), Ga-68 (Gallium-68)
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Cardinal Health, Bayer AG, Medtronic plc, Siemens Healthineers AG, Fujifilm Holdings Corporation, Stryker Corporation, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Agfa HealthCare NV, Scripps Health, Shimadzu Corporation, Jubilant DraxImage Inc., Neusoft Medical Systems Co. Ltd., Toshiba America Medical Systems Inc., Lantheus Holdings Inc., Advanced Accelerator Applications, Bruker Corporation, Eckert & Ziegler Strahlen- und Medizintechnik AG, Canon Medical Systems Corporation, Digirad Corporation, NorthStar Medical Radioisotopes LLC, Mediso Medical Imaging Systems Ltd.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Positron Emission Tomography (PET) Nuclear Medicine Market Characteristics

    3. Positron Emission Tomography (PET) Nuclear Medicine Market Trends And Strategies

    4. Positron Emission Tomography (PET) Nuclear Medicine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

    5. Global Positron Emission Tomography (PET) Nuclear Medicine Growth Analysis And Strategic Analysis Framework

    5.1. Global Positron Emission Tomography (PET) Nuclear Medicine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Positron Emission Tomography (PET) Nuclear Medicine Market Growth Rate Analysis

    5.4. Global Positron Emission Tomography (PET) Nuclear Medicine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Positron Emission Tomography (PET) Nuclear Medicine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Positron Emission Tomography (PET) Nuclear Medicine Total Addressable Market (TAM)

    6. Positron Emission Tomography (PET) Nuclear Medicine Market Segmentation

    6.1. Global Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    F-18

    Rb-82

    Other Types

    6.2. Global Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Diagnostic Procedures

    Single Photon Emission Computed Tomography Procedures

    Positron Emission Tomography Procedures

    Therapeutic Procedures

    Beta Emitter Procedures

    Alpha Emitter Procedures

    6.3. Global Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Oncology

    Cardiology

    Neurology

    Other Applications

    6.4. Global Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hospitals

    Diagnostic Centers

    Research Institutes

    6.5. Global Positron Emission Tomography (PET) Nuclear Medicine Market, Sub-Segmentation Of F-18 (Fluorine-18), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    F-18 FDG (Fluorodeoxyglucose)

    F-18 NaF (Sodium Fluoride)

    F-18 Fluorocholine

    6.6. Global Positron Emission Tomography (PET) Nuclear Medicine Market, Sub-Segmentation Of Rb-82 (Rubidium-82), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Rb-82 for Myocardial Perfusion Imaging

    Rb-82 for Cardiac PET Stress Testing

    Rb-82 for Other Cardiac Applications

    6.7. Global Positron Emission Tomography (PET) Nuclear Medicine Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    C-11 (Carbon-11)

    N-13 (Nitrogen-13)

    O-15 (Oxygen-15)

    Ga-68 (Gallium-68)

    7. Positron Emission Tomography (PET) Nuclear Medicine Market Regional And Country Analysis

    7.1. Global Positron Emission Tomography (PET) Nuclear Medicine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Positron Emission Tomography (PET) Nuclear Medicine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Positron Emission Tomography (PET) Nuclear Medicine Market

    8.1. Asia-Pacific Positron Emission Tomography (PET) Nuclear Medicine Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Positron Emission Tomography (PET) Nuclear Medicine Market

    9.1. China Positron Emission Tomography (PET) Nuclear Medicine Market Overview

    9.2. China Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Positron Emission Tomography (PET) Nuclear Medicine Market

    10.1. India Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Positron Emission Tomography (PET) Nuclear Medicine Market

    11.1. Japan Positron Emission Tomography (PET) Nuclear Medicine Market Overview

    11.2. Japan Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Positron Emission Tomography (PET) Nuclear Medicine Market

    12.1. Australia Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Positron Emission Tomography (PET) Nuclear Medicine Market

    13.1. Indonesia Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Positron Emission Tomography (PET) Nuclear Medicine Market

    14.1. South Korea Positron Emission Tomography (PET) Nuclear Medicine Market Overview

    14.2. South Korea Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Positron Emission Tomography (PET) Nuclear Medicine Market

    15.1. Western Europe Positron Emission Tomography (PET) Nuclear Medicine Market Overview

    15.2. Western Europe Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Positron Emission Tomography (PET) Nuclear Medicine Market

    16.1. UK Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Positron Emission Tomography (PET) Nuclear Medicine Market

    17.1. Germany Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Positron Emission Tomography (PET) Nuclear Medicine Market

    18.1. France Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Positron Emission Tomography (PET) Nuclear Medicine Market

    19.1. Italy Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Positron Emission Tomography (PET) Nuclear Medicine Market

    20.1. Spain Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Positron Emission Tomography (PET) Nuclear Medicine Market

    21.1. Eastern Europe Positron Emission Tomography (PET) Nuclear Medicine Market Overview

    21.2. Eastern Europe Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Positron Emission Tomography (PET) Nuclear Medicine Market

    22.1. Russia Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Positron Emission Tomography (PET) Nuclear Medicine Market

    23.1. North America Positron Emission Tomography (PET) Nuclear Medicine Market Overview

    23.2. North America Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Positron Emission Tomography (PET) Nuclear Medicine Market

    24.1. USA Positron Emission Tomography (PET) Nuclear Medicine Market Overview

    24.2. USA Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Positron Emission Tomography (PET) Nuclear Medicine Market

    25.1. Canada Positron Emission Tomography (PET) Nuclear Medicine Market Overview

    25.2. Canada Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Positron Emission Tomography (PET) Nuclear Medicine Market

    26.1. South America Positron Emission Tomography (PET) Nuclear Medicine Market Overview

    26.2. South America Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Positron Emission Tomography (PET) Nuclear Medicine Market

    27.1. Brazil Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Positron Emission Tomography (PET) Nuclear Medicine Market

    28.1. Middle East Positron Emission Tomography (PET) Nuclear Medicine Market Overview

    28.2. Middle East Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Positron Emission Tomography (PET) Nuclear Medicine Market

    29.1. Africa Positron Emission Tomography (PET) Nuclear Medicine Market Overview

    29.2. Africa Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Positron Emission Tomography (PET) Nuclear Medicine Market Competitive Landscape And Company Profiles

    30.1. Positron Emission Tomography (PET) Nuclear Medicine Market Competitive Landscape

    30.2. Positron Emission Tomography (PET) Nuclear Medicine Market Company Profiles

    30.2.1. Cardinal Health Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. Fujifilm Holdings Corporation Overview, Products and Services, Strategy and Financial Analysis

    31. Positron Emission Tomography (PET) Nuclear Medicine Market Other Major And Innovative Companies

    31.1. Stryker Corporation

    31.2. GE HealthCare Technologies Inc.

    31.3. Koninklijke Philips N.V.

    31.4. Agfa HealthCare NV

    31.5. Scripps Health

    31.6. Shimadzu Corporation

    31.7. Jubilant DraxImage Inc.

    31.8. Neusoft Medical Systems Co. Ltd.

    31.9. Toshiba America Medical Systems Inc.

    31.10. Lantheus Holdings Inc.

    31.11. Advanced Accelerator Applications

    31.12. Bruker Corporation

    31.13. Eckert & Ziegler Strahlen- und Medizintechnik AG

    31.14. Canon Medical Systems Corporation

    31.15. Digirad Corporation

    32. Global Positron Emission Tomography (PET) Nuclear Medicine Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Positron Emission Tomography (PET) Nuclear Medicine Market

    34. Recent Developments In The Positron Emission Tomography (PET) Nuclear Medicine Market

    35. Positron Emission Tomography (PET) Nuclear Medicine Market High Potential Countries, Segments and Strategies

    35.1 Positron Emission Tomography (PET) Nuclear Medicine Market In 2029 - Countries Offering Most New Opportunities

    35.2 Positron Emission Tomography (PET) Nuclear Medicine Market In 2029 - Segments Offering Most New Opportunities

    35.3 Positron Emission Tomography (PET) Nuclear Medicine Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Sub-Segmentation Of F-18 (Fluorine-18), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Sub-Segmentation Of Rb-82 (Rubidium-82), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Cardinal Health Financial Performance
  • Table 79: Bayer AG Financial Performance
  • Table 80: Medtronic plc Financial Performance
  • Table 81: Siemens Healthineers AG Financial Performance
  • Table 82: Fujifilm Holdings Corporation Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Sub-Segmentation Of F-18 (Fluorine-18), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Sub-Segmentation Of Rb-82 (Rubidium-82), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Positron Emission Tomography (PET) Nuclear Medicine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Positron Emission Tomography (PET) Nuclear Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Cardinal Health Financial Performance
  • Figure 79: Bayer AG Financial Performance
  • Figure 80: Medtronic plc Financial Performance
  • Figure 81: Siemens Healthineers AG Financial Performance
  • Figure 82: Fujifilm Holdings Corporation Financial Performance

Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis

Read More

How Will The Nuclear Medicine Market Grow In 2022?

Read More

What Is The Pediatric Imaging Market Overview In 2022?

Read More

Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company

Read More

The Business Research Company offers the medical aesthetics market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the clinical chemistry market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth

Read More

Nuclear Electric Power Generation Global Market Report 2020 - By Reactor Type (Pressurized Water Reactors (PWR), Fast Breeder Reactor (FBR), Pressurized Heavy-Water Reactor (PHWR), Boiling Water Reactor (BWR), Light Water Graphite Reactor (LWGR), Gas-Cooled Reactor (GCR)), By End-User (Residential, Commercial, Industrial)

View Report

Emission Monitoring System Global Market Report 2025 – By System Type (Continuous Emission Monitoring System (CEMS), Predictive Emission Monitoring System (PEMS)), By Component Outlook (Hardware, Software, Service), By Industry (Marine And Shipping, Mining, Metals, Pharmaceuticals, Pulp And Paper, Building Materials, Chemicals, Petrochemicals, Refineries And Fertilizers, Oil And Gas, Power Generation) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Emission Management Software Global Market Report 2025 – By Component( Software, Service), By Product Type( Cloud-Based, Web-Based), By Application( Small And Medium Enterprises, Large Enterprises), By Industry( Manufacturing, IT And Telecom, Government Sector, Energy And Power, Other Industries) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Positron Emission Tomography (PET) Scanners Global Market Report 2025 – By Modality (PET-CT (Positron Emission Tomography-Computed Tomography), PET-MRI (Positron Emission Tomography-Magnetic Resonance Imaging)), By Detector Type (Gadolinium Oxyorthosilicate, Lutetium Fine Silicate, Bismuth Germanium Oxide, Lutetium Oxyorthosilicate), By Application (Cardiology, Neurology, Oncology, Orthopedics, Urology, Gastroenterology, Other Applications), By End User (Hospitals, Diagnostic Centers, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Single-Photon Emission Computed Tomography (SPECT) Global Market Report 2025 – By Type (Hybrid SPECT Systems, Standalone SPECT Systems), By Type Of Radioisotopes (Tc-99m, Ra-223, Ga-67, I-123, Other Radioisotopes), By Application (Oncology, Cardiology, Neurology, Other Applications), By End User (Hospitals, Diagnostic Centers, Other End User) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Nuclear Medicine Global Market Report 2025 – By Type (Diagnostic, Therapeutic), By Application (Cardiology, Lymphoma, Thyroid, Neurology, Oncology, Other Application), By End-User (Hospitals and Clinics, Diagnostic Centers, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Nuclear Medicine Diagnostics Global Market Report 2025 – By Type (SPECT Radiopharmaceuticals, PET Radiopharmaceuticals), By Application (Cardiology, Thyroid, Neurology, Oncology, Other Applications), By End-User (Hospitals And Diagnostic Centers, Research Institutes) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Nuclear Imaging Devices And Equipment Global Market Report 2025 – By Product Type (SPECT Systems, PET Systems, Planar Scintigraphy Systems), By Application (Oncology, Cardiology, Neurology, Other Applications), By End-User (Hospitals, Imaging Centers, Academic & Research Institutes, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Positron Emission Tomography (PET) Nuclear Medicine market?

Positron Emission Tomography (PET) nuclear medicine is a medical imaging method that employs radioactive materials to visualize and assess metabolic activities within the body. It uses a small amount of radioactive material called a radiotracer to detect changes at the cellular level, allowing doctors to diagnose diseases early. For further insights on the Positron Emission Tomography (PET) Nuclear Medicine market, request a sample here

How will the Positron Emission Tomography (PET) Nuclear Medicine market drivers and restraints affect the market dynamics? What forces will shape the Positron Emission Tomography (PET) Nuclear Medicine industry going forward?

The Positron Emission Tomography (PET) Nuclear Medicine market major growth driver - Impact Of Chronic Disease Prevalence On The PET Nuclear Medicine Market. For further insights on the Positron Emission Tomography (PET) Nuclear Medicine market, request a sample here

What is the forecast market size or the forecast market value of the Positron Emission Tomography (PET) Nuclear Medicine market?

The Positron Emission Tomography (PET) Nuclear Medicine market size has grown strongly in recent years. The positron emission tomography (PET) nuclear medicine market size has grown rapidly in recent years. It will grow from $11.49 billion in 2024 to $13.2 billion in 2025 at a compound annual growth rate (CAGR) of 14.9%. The growth in the historic period can be attributed to increasing prevalence of cardiovascular diseases, increasing healthcare expenditures, increasing prevalence of urological diseases, increasing geriatric population, and increasing number of hospitals. The positron emission tomography (PET) nuclear medicine market size is expected to see rapid growth in the next few years. It will grow to $22.71 billion in 2029 at a compound annual growth rate (CAGR) of 14.5%. The growth in the forecast period can be attributed to increasing investment in research and development, rising demand for minimally invasive diagnostic techniques, expanding global healthcare infrastructure, increasing demand for food and pharmaceutical packaging, and rising prevalence of cancer. Major trends in the forecast period include technological advancements, multi-modality diagnosis, artificial intelligence integration, digital PET systems, and personalized medicine. For further insights on the Positron Emission Tomography (PET) Nuclear Medicine market, request a sample here

How is the Positron Emission Tomography (PET) Nuclear Medicine market segmented?

The positron emission tomography (PET) nuclear medicine market covered in this report is segmented –
1) By Type: F-18, Rb-82, Other Types
2) By Procedure: Diagnostic Procedures, Single Photon Emission Computed Tomography Procedures, Positron Emission Tomography Procedures, Therapeutic Procedures, Beta Emitter Procedures, Alpha Emitter Procedures, Brachytherapy Procedures
3) By Application: Oncology, Cardiology, Neurology, Other Applications
4) By End User: Hospitals, Diagnostic Centers, Research Institutes
Subsegments:
1) By F-18 (Fluorine-18): F-18 FDG (Fluorodeoxyglucose), F-18 NaF (Sodium Fluoride), F-18 Fluorocholine
2) By Rb-82 (Rubidium-82): Rb-82 for Myocardial Perfusion Imaging, Rb-82 for Cardiac PET Stress Testing, Rb-82 for Other Cardiac Applications
3) By Other Types: C-11 (Carbon-11), N-13 (Nitrogen-13), O-15 (Oxygen-15), Ga-68 (Gallium-68) For further insights on the Positron Emission Tomography (PET) Nuclear Medicine market, request a sample here

Which region has the largest share of the Positron Emission Tomography (PET) Nuclear Medicine market? What are the other regions covered in the report?

North America was the largest region in the positron emission tomography (PET) nuclear medicine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the positron emission tomography (PET) nuclear medicine marker report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Positron Emission Tomography (PET) Nuclear Medicine market, request a sample here.

Who are the major players in the Positron Emission Tomography (PET) Nuclear Medicine market?

Major companies operating in the positron emission tomography (PET) nuclear medicine marker are Cardinal Health, Bayer AG, Medtronic plc, Siemens Healthineers AG, Fujifilm Holdings Corporation, Stryker Corporation, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Agfa HealthCare NV, Scripps Health, Shimadzu Corporation, Jubilant DraxImage Inc., Neusoft Medical Systems Co. Ltd., Toshiba America Medical Systems Inc., Lantheus Holdings Inc., Advanced Accelerator Applications, Bruker Corporation, Eckert & Ziegler Strahlen- und Medizintechnik AG, Canon Medical Systems Corporation, Digirad Corporation, NorthStar Medical Radioisotopes LLC, Mediso Medical Imaging Systems Ltd. . For further insights on the Positron Emission Tomography (PET) Nuclear Medicine market, request a sample here.

What are the key trends in the Positron Emission Tomography (PET) Nuclear Medicine market?

Major trends in the Positron Emission Tomography (PET) Nuclear Medicine market include Advancements In The PET Nuclear Medicine Market. For further insights on the Positron Emission Tomography (PET) Nuclear Medicine market, request a sample here.

What are the major opportunities in the Positron Emission Tomography (PET) Nuclear Medicine market? What are the strategies for the Positron Emission Tomography (PET) Nuclear Medicine market?

For detailed insights on the major opportunities and strategies in the Positron Emission Tomography (PET) Nuclear Medicine market, request a sample here.

How does the Positron Emission Tomography (PET) Nuclear Medicine market relate to the overall economy and other similar markets?

For detailed insights on Positron Emission Tomography (PET) Nuclear Medicine's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Positron Emission Tomography (PET) Nuclear Medicine industry?

For detailed insights on the mergers and acquisitions in the Positron Emission Tomography (PET) Nuclear Medicine industry, request a sample here.

What are the key dynamics influencing the Positron Emission Tomography (PET) Nuclear Medicine market growth? SWOT analysis of the Positron Emission Tomography (PET) Nuclear Medicine market.

For detailed insights on the key dynamics influencing the Positron Emission Tomography (PET) Nuclear Medicine market growth and SWOT analysis of the Positron Emission Tomography (PET) Nuclear Medicine industry, request a sample here.